Frost edit · Free shipping over $70 · Cool essentials
Login Register
dihexa retracted paper controversy

dihexa retracted paper controversy from Q1 Scopus & Web of Science Journal. Why did it happen? Because the publisher found 38 FAKE references in the paper. The author admitted they used AI to generate Retraction | The Transmitter: Neuroscience

SKU: 10649757241
4.3
USD29.59 USD53.59

Pay in 4 interest-free payments of $7.40 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 19 - Aug 24

Description

At Regency Medical Spa & Hair Clinic, your health and safety are our top priorities

dihexa retracted paper controversy from Q1 Scopus & Web of Science Journal. Why did it happen? Because the publisher found 38 FAKE references in the paper. The author admitted they used AI to generate Retraction | The Transmitter: Neuroscience

To learn how to talk to your patient and calm them down before giving an injection, read more from our Nurse co-author

dihexa retracted paper controversy from Q1 Scopus & Web of Science Journal. Why did it happen? Because the publisher found 38 FAKE references in the paper. The author admitted they used AI to generate Retraction | The Transmitter: Neuroscience

Scientific Backing and Clinical Research Extensive preclinical studies and emerging clinical trials underscore retatrutides remarkable efficacy

dihexa retracted paper controversy from Q1 Scopus & Web of Science Journal. Why did it happen? Because the publisher found 38 FAKE references in the paper. The author admitted they used AI to generate Retraction | The Transmitter: Neuroscience

Ongoing research aims to establish evidence-based dosing protocols for therapeutic applications

dihexa retracted paper controversy from Q1 Scopus & Web of Science Journal. Why did it happen? Because the publisher found 38 FAKE references in the paper. The author admitted they used AI to generate Retraction | The Transmitter: Neuroscience

BPC 157 can enhance the expression and endocytosis of VEGFR2, and subsequently the phosphorylation of AKT and eNOS as proved in our previous study 6

dihexa retracted paper controversy from Q1 Scopus & Web of Science Journal. Why did it happen? Because the publisher found 38 FAKE references in the paper. The author admitted they used AI to generate Retraction | The Transmitter: Neuroscience

It showed excellent safety with no serious adverse events and no IGF-1 elevation

dihexa retracted paper controversy from Q1 Scopus & Web of Science Journal. Why did it happen? Because the publisher found 38 FAKE references in the paper. The author admitted they used AI to generate Retraction | The Transmitter: Neuroscience
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

Frontiers
Frontiers

US$ 29.35

4.8 (11 reviews)

ESSENCE
ESSENCE

US$ 20.78

4.3 (17 reviews)

recommand products